• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Technology·GTLB
Held by 3 Gurus
Share

GitLab Inc. Stocks

$ 34.51Last Updated 31.07.2026

Issuer Rating

3/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 5.83B

$ 34.51
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Cathie Wood

Portfolio Weight (%)

0.1%

Change

-0.07%

Fund

ARK Investment Management LLC

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

-0.00%

Fund

CITADEL ADVISORS LLC

Steven Cohen

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

Point72 Asset Management, L.P.

Manager
Fund
Portfolio Weight (%)
Change
Cathie WoodARK Investment Management LLC0.1%-0.07%
Kenneth GriffinCITADEL ADVISORS LLC0.0%-0.00%
Steven CohenPoint72 Asset Management, L.P.0.0%+0.00%

Latest news

21.07.2026 21:43

Citrini, Who Spooked the Market with Her AI Threat Forecast, Named Three AI Stocks to Buy

20.06.2026 16:01

Small caps last week: Anthropic IPO beneficiaries, GLP-1 craze winners, biotech rally

17.06.2026 17:25

Ahead of potential Anthropic IPO, here are four smid caps that stand to gain.

25.04.2026 16:01

Small caps last week: U.S.-Iran talks, rare earths, U.S. drug policy easing, chips

22.04.2026 15:48

Motley Fool analyst says software maker GitLab 'too cheap to ignore'

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

GitLab Inc., through its various operating entities, specializes in developing software solutions that facilitate the entire software development lifecycle. The company's operations span the United States, Europe, and the Asia Pacific regions. Its primary offering is GitLab, a unified DevOps platform. This single application is engineered to boost development speed, offering extensive visibility and precise command over every phase of the DevOps workflow. The platform's objective is to enable businesses to effectively plan, build, secure, and release software, thereby driving positive business results. Additionally, GitLab Inc. provides a range of associated training and expert consultation services. Founded in 2011, the enterprise was initially known as GitLab B.V. before officially adopting the name GitLab Inc. in July 2015. The firm's main offices are located in San Francisco, California.

Company Valuation

Overvalued
2/7

From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, r

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of GTLB is 36.3 and suggests 5.3% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

03.08.2026 17:55

AstraZeneca shares plummeted following news of a mega-deal with Bristol Myers

03.08.2026 17:38

A Motley Fool analyst called it a "safe bet" in the cannabis market

03.08.2026 16:54

"Valuations Are Reasonable Again": What Analysts Are Advising After the Sell-Off of Former Favorites

03.08.2026 16:10

After the July sell-off: Has the golden age for chipmakers come to an end?

03.08.2026 15:20

Warsh suggested that the Fed might reduce the number of meetings on interest rates

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026